Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

Benutzer: Gast

Titel:: Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Ziegler, Anette-Gabriele; Achenbach, Peter; Berner, Reinhard; Casteels, Kristina; Danne, Thomas; Gündert, Melanie; Hasford, Joerg; Hoffmann, Verena Sophia; Kordonouri, Olga; Lange, Karin; Elding Larsson, Helena; Lundgren, Markus; Snape, Matthew D; Szypowska, Agnieszka; Todd, John A; Bonifacio, Ezio
Zeitschriftentitel:: BMJ Open
Jahr:: 2019
Band / Volume:: 9
Heft / Issue:: 6
Seitenangaben Beitrag:: e028578
Volltext / DOI:: doi:10.1136/bmjopen-2018-028578
Verlag / Institution:: BMJ
E-ISSN:: 2044-60552044-6055
Publikationsdatum:: 01.06.2019
BibTeX

Vorkommen: